| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/08/2009 | US20090012494 Intradermal delivery of biological agents |
| 01/08/2009 | US20090012271 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012268 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine |
| 01/08/2009 | US20090012267 Anti-hydroxylase antibodies and uses thereof |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090010985 Article with Lubricated Surface and Method |
| 01/08/2009 | US20090010967 Clostridial toxin derivatives and methods for treating pain |
| 01/08/2009 | US20090010966 Modified diphtheria toxins |
| 01/08/2009 | US20090010965 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 01/08/2009 | US20090010964 Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines |
| 01/08/2009 | US20090010963 Raccoon Poxvirus Expressing Rabies Glycoproteins |
| 01/08/2009 | US20090010962 Genetically Engineered Swine Influenza Virus and Uses Thereof |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010960 Bacteriophage-mediated immunisation against hepatitis |
| 01/08/2009 | US20090010959 Complex containing diphtheria toxins |
| 01/08/2009 | US20090010957 Immunogenic Mycoplasma Hyopneumoniae Polypeptides |
| 01/08/2009 | US20090010956 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 01/08/2009 | US20090010955 Vaccines Containing Canine Parvovirus Genetic Variants |
| 01/08/2009 | US20090010954 Prevention and treatment of sub-clinical pcvd |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010952 Pharmaceutical compound for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt or erp57 translocation |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 01/08/2009 | US20090010949 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 01/08/2009 | US20090010948 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 01/08/2009 | US20090010947 Red Microalgae Expressing Exogenous Polypeptides And Methods Of Generating And Utilizing Same |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010945 conjugating drug to antibody by reducing antibody with reducing agent, treating antibody with reoxidizing agent to reform interchain disulfide bond of antibody to form partially reoxidized antibody such that two cysteine thiols remain, conjugating drug to interchain thiol of antibody via maleimide group |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010941 Methods for treating HIV |
| 01/08/2009 | US20090010940 Parathyroid Hormone Analogues and Methods of Use |
| 01/08/2009 | US20090010939 Administering a monoclonal anti-CD80 antibody or CD80 binding fragment that binds specifically to human CD80 antigen and inhibits binding of the CD80 antigen to CD28 without inhibiting the binding of the CD80 antigen to CTLA-4; immunosuppressants, autoimmune diseases, transplant rejection |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |
| 01/08/2009 | US20090010937 Membrane Attack Complexes Associated with Circulating Immune Complexes |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010934 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010932 Gb virus c (hepatitis g virus) for the treatment of hiv |
| 01/08/2009 | US20090010931 restoring growth inhibition sensitivity to a tumor cell resistant to growth inhibition by HER2 antagonists; antibody produced by the hybridoma 4F10; PC-Cell Derived Growth Factor (PCDGF) |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010929 Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates |
| 01/08/2009 | US20090010928 Anti-anthrax antibody, formulations thereof, and methods of use |
| 01/08/2009 | US20090010927 Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
| 01/08/2009 | US20090010926 Extended Treatment of Multiple Sclerosis |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010923 Treatment of cancer with anti-muscarinic receptor agents |
| 01/08/2009 | US20090010922 Compositions and methods for binding sphingosine-1-phosphate |
| 01/08/2009 | US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 01/08/2009 | US20090010920 Fc Variants Having Decreased Affinity for FcyRIIb |
| 01/08/2009 | US20090010919 Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap) |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010891 Sepsis Treatment Agent |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | US20090010885 Methods for Detecting and Treating Autoimmune Disorders |
| 01/08/2009 | US20090010883 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of metastatic gastric or stomach cancer |
| 01/08/2009 | US20090010881 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of bladder cancer |
| 01/08/2009 | US20090010876 Visfatin and uses thereof |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010845 Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery |
| 01/08/2009 | US20090010843 Methods of Identifying Antibodies to Ligands of Orphan Receptors |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | CA2692603A1 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | CA2692509A1 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | CA2692392A1 Anti- mcp-1 antibodies, compositions, methods and uses |
| 01/08/2009 | CA2692340A1 Production of an homogeneous vaccine preparation for cancer treatment |
| 01/08/2009 | CA2692320A1 Methods of treating bone disorders with modulators of axl |
| 01/08/2009 | CA2692149A1 Vaccine production for pathogenic bird viral diseases |
| 01/08/2009 | CA2691962A1 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli |
| 01/08/2009 | CA2691868A1 Immortalized avian cell lines |
| 01/08/2009 | CA2691840A1 The use of monomycolyl glycerol (mmg) as an adjuvant |
| 01/08/2009 | CA2691734A1 Anti-muc17 antibody |
| 01/08/2009 | CA2691629A1 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691618A1 Mdl-1 uses |
| 01/08/2009 | CA2687223A1 Diagnostic composition and method for the detection of a trichinella infection |
| 01/07/2009 | EP2012124A2 Method for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 01/07/2009 | EP2012123A1 Marker for predicting graft-versus-host disease and utilization of the same |
| 01/07/2009 | EP2012122A1 Mutated parvovirus structural proteins as vaccines |
| 01/07/2009 | EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011876A1 Dna vaccine for koi herpes virus (khv) disease |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011867A1 Pseudomonas aeruginosa outer membrane protein pa0427 |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011513A1 Therapeutic agents for alzheimer's disease and cancer |